Orchard Therapeutics North America is a biopharmaceutical company based in Massachusetts that develops gene therapies. It lobbies on health-related laws, including Medicare and Medicaid policies, newborn screening funding, and value-based payment programs for Medicaid to help patients—especially children—get access to treatments. The filings show they spent about $1.4 million and made multiple filings through 2026.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
CHRISTINA HARTMAN
The latest disclosures for this client.
ORCHARD THERAPEUTICS NORTH AMERICA
1AORCHARD THERAPEUTICS NORTH AMERICA
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
These contribution items line up to this client through the same lobbying firm and reporting window, and when available the same contributing lobbyist.
ORCHARD THERAPEUTICS NORTH AMERICA
BRITTANY DUFFY
ORCHARD THERAPEUTICS NORTH AMERICA
ORCHARD THERAPEUTICS NORTH AMERICA
2AORCHARD THERAPEUTICS NORTH AMERICA
Q4ORCHARD THERAPEUTICS NORTH AMERICA
Q3ORCHARD THERAPEUTICS NORTH AMERICA
RAORCHARD THERAPEUTICS NORTH AMERICA
Q2ORCHARD THERAPEUTICS NORTH AMERICA
Q1